Celanese Corporation (CE) announced that it will participate at the Annual Meeting & Exposition of the Controlled Release Society (CRS) in Chicago, Ill., for a poster session entitled “Predictive Modeling and Validation of Tamoxifen Release from Ethylene Vinyl Acetate (EVA) Copolymers” to be presented on Jul 13.
Celanese EVA Performance Polymers can help pharmaceutical companies develop novel, controlled release products based on its EVA polymers. EVA excipients boast unique performance properties that offer pharmaceutical manufacturers new product possibilities.
Celanese’s VitalDose Ethylene Vinyl Acetate (EVA)-based excipients deliver the reliable performance required for pharma and medical device applications. EVA is an easy to process material and the VitalDose brand represents a commitment to each of its customers to help them realize their product objectives. The study demonstrates the versatility of VitalDose EVA, offering predictively-modeled dosage of the main oncology drug Tamoxifen.
EVA was assessed in the study with selected active pharmaceutical ingredients (APIs). The API solubility and release profiles were studied using Hansen Solubility Parameter calculations and experimental in vitro elution. The study showed a method that can be used for initial formulation design for controlled drug delivery from EVA copolymers.
Celanese posted better-than-expected first-quarter 2014 results on Apr 21. Both revenues and adjusted earnings for the quarter topped the Zacks Consensus Estimate.
Celanese holds a Zacks Rank #2 (Buy).
Other companies in the chemical space worth considering include KMG Chemicals Inc. (KMG), Minerals Technologies Inc. (MTX) and Ashland Inc. (ASH) While KMG Chemicals and Minerals Technologies sport a Zacks Rank #1 (Strong Buy), Ashland holds a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment